Literature DB >> 19856065

Nonspecific interstitial pneumonia pattern as pulmonary involvement in human T-cell lymphotropic virus type 1 carriers.

Hui Yu1, Jiro Fujita, Futoshi Higa, Ichiro Yamadori, Kenji Hibiya, Satomi Yara, Masao Tateyama, Yasushi Tanimoto, Mitsune Tanimoto, Huiping Li.   

Abstract

It is well established that diffuse interstitial shadows are observed in human T-cell lymphotropic virus type 1 (HTLV-1) carriers. However, the pathological pattern of nonspecific interstitial pneumonia (NSIP) has rarely been reported. Here, we describe the clinical features of four patients with histologically proven NSIP and HTLV-1 infection. The patients, one woman and three men, had a median age of 59.5 years. High-resolution computed tomography of the lungs was performed in all patients, and no apparent honeycomb formations were detected. The present study demonstrates that the NSIP pattern is a significant pathological classification of interstitial pneumonia associated with HTLV-1 carriers.

Entities:  

Mesh:

Year:  2009        PMID: 19856065     DOI: 10.1007/s10156-009-0707-7

Source DB:  PubMed          Journal:  J Infect Chemother        ISSN: 1341-321X            Impact factor:   2.211


  3 in total

1.  Effectiveness of Combined Therapy with Pirfenidone and Erythromycin for Unclassifiable Interstitial Pneumonia Induced by HTLV-1-associated Bronchioloalveolar Disorder (HABA).

Authors:  Naoko Yokohori; Akitoshi Sato; Mizue Hasegawa; Hideki Katsura; Kenzo Hiroshima; Tamiko Takemura
Journal:  Intern Med       Date:  2017-01-01       Impact factor: 1.271

Review 2.  The Role of Infection in Interstitial Lung Diseases: A Review.

Authors:  Natalya Azadeh; Andrew H Limper; Eva M Carmona; Jay H Ryu
Journal:  Chest       Date:  2017-04-08       Impact factor: 9.410

Review 3.  Human T-cell leukaemia virus type 1 associated pulmonary disease: clinical and pathological features of an under-recognised complication of HTLV-1 infection.

Authors:  Lloyd Einsiedel; Fabian Chiong; Hubertus Jersmann; Graham P Taylor
Journal:  Retrovirology       Date:  2021-01-06       Impact factor: 4.602

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.